FeesSafety
Pluang+

BillionToOne rejects short seller report, defends business and plans legal action

Market News
18 Nov 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
BillionToOne rejects short seller report, defends business and plans legal action

BillionToOne, a molecular diagnostics firm, responded to a short seller report by Fuzzy Panda Research that it says contains false and misleading claims aimed at driving down its stock price. The company stands by the integrity of its business, the quality of its tests, and compliance with laws. BillionToOne is reviewing legal options to address the report. CEO Oguzhan Atay emphasized the company's commitment to transparency and patient care amid the dispute.

BillionToOne's response to a short seller report provides context for readers following health-sector stocks. For readers following health-sector US stocks on Pluang, here is the market snapshot as of Nov 19, 2026 04:02 WIB: out of 150 priced stocks, 49 rose and 100 fell. Notable movers include INO (Inovio Pharmaceuticals Inc) at USD 1.66 with a 1-day change of +18.57% and Pluang order activity of 54% Sell / 46% Buy, UNH (UnitedHealth Group Inc) at USD 349.73 down -10.25% with 88% Sell / 12% Buy, and WGS (GeneDx Holdings Corp) at USD 52.09 up +10.15% with 99% Sell / 1% Buy.

More News

Alpha Tau Medical reports positive trial results ahead of earnings on Nov 19, 2026.

Alpha Tau Medical reports positive trial results ahead of earnings on Nov 19, 2026.

Alpha Tau Medical is set to report earnings on November 19, 2026, with expected losses of $0.15 per share and revenue of $125,000. The company announced positive clinical trial results from its U.S. REGAIN trial for Alpha DaRT therapy in glioblastoma...

Company Fundamentals
Bullish
54 minutes ago
Nvidia shares fall 2.9% despite strong earnings and raised revenue forecast amid leadership and regulatory concerns.

Nvidia shares fall 2.9% despite strong earnings and raised revenue forecast amid leadership and regulatory concerns.

Nvidia's stock dropped 2.9% to $150.96 after initially rising on strong quarterly results and a raised revenue forecast for fiscal 2028, projecting 75% annual growth. However, investor concerns about leadership uncertainty, including calls for former...

Neutral
1 hour ago
B&G Foods raises full-year sales and EBITDA guidance on strong volume growth and debt reduction plans

B&G Foods raises full-year sales and EBITDA guidance on strong volume growth and debt reduction plans

B&G Foods increased its full-year net sales and adjusted EBITDA guidance following a 5% volume-driven sales growth in Q3 2026. The company is expanding beyond traditional retail into food service, clubs, and private labels to utilize factory capacity...

Company Fundamentals
Bullish
1 hour ago
CoreWeave shares drop 4.13% amid strong AI demand but investor worries over debt and financing costs.

CoreWeave shares drop 4.13% amid strong AI demand but investor worries over debt and financing costs.

CoreWeave's stock fell 4.13% despite strong AI demand and Nvidia's solid earnings, as investors focus on the company's heavy debt and financing challenges. The company reported 168% revenue growth and raised its 2026 revenue forecast to $13-$13.3 bil...

Bearish
1 hour ago
Performance Food Group posts 5.5% sales growth, targets $125M procurement savings by 2028

Performance Food Group posts 5.5% sales growth, targets $125M procurement savings by 2028

Performance Food Group reported a 5.5% net sales increase in fiscal Q1 2027, driven by growth in independent restaurant orders and expanding gross profit margins. The company aims to achieve $125 million in annual procurement savings by fiscal 2028 t...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App